Industry News
Amgen ready to go shopping
Global biotech company Amgen has acknowledged that proposed changes to the R&D tax credit arrangements would increase the appeal of the Australian biotech industry as the company prepares to embark on a global spending spree. [ + ]
Roundtable: from innovation to commercialisation - Part III: closing comments
In this final part of the roundtable discussion the panellists address the role of government in commercialisation and then provide their closing comments on how we can improve the system in Australia. [ + ]
Roundtable: from innovation to commercialisation - Part I: research and business
It's the perennial question: how do we effectively translate cutting edge research into successful products in the market? Australian Life Scientist brought together a panel of industry luminaries to discuss the challenges of commercialisation in Australia. [ + ]
Nanotech lets doctors camera see cancer cells
Researchers have added nanoechnology to an off-the-shelf digital camera to help doctors distinguish healthy cells from cancerous cells in the human body. [ + ]
Market report: Jitters return following poor U.S economic data
Australian shares slumped to a fortnightly low on Friday, weighed down by concerns about the U.S and Europe as well as uncertainty surrounding the proposed resources super profits tax (RSPT). [ + ]
ImpediMed clears final U.S hurdle for biompedance product
Brisbane biotech ImpediMed announced today that it has received a Category III coding from the American Medical Association ( AMA ) for the use of its L-Dex U400 bioimpedance spectroscopy ( BIS ) technology in the detection of lymphoedema in limbs, which will take effect on January 1 next year. [ + ]
Human Genome Project, 10 years on
10 years ago, on June 26, 2000, the first draft of the human genome was announced to the public with great ceremony and aplomb. And hyperbole. [ + ]
Revolutionary new Alzheimer’s test awaits FDA approval
A U.S company is nearing approval for a new scanning and dye procedure which could revolutionise the diagnosis and treatment of Alzheimer’s. [ + ]
First cannabis-based drug approved in Europe
The first cannabis-based pharmaceutical product has been approved in the UK, paving the way for widespread adoption throughout Europe. [ + ]
Major new African gene study announced
An ambitious new health project announced this week will seek to capitalise on Africa’s unique genetic diversity in a bid to further understanding of how genes interact with the environment in relation to diseases such as cancer, heart disease and malaria. [ + ]
Melanoma cases to double over next decade
The number of melanoma cases will double over the next 10 years, presenting attractive opportunities for drug companies to improve on existing poor and outdated standards of treatment. [ + ]
Melanoma cases to double over next decade
The number of cases of melanoma will double over the next 10 years, presenting attractive opportunities for drug companies to improve on existing poor and outdated standards of treatment. [ + ]
Green chemistry award for Dow and BASF’s HPPO technology
Dow Chemical and BASF have received a green chemistry award for their jointly developed hydrogen peroxide to propylene oxide (HPPO) technology.
[ + ]Research committee named for SAHMRI
A who’s who of Australian scientists have been tapped to direct the research of the new South Australian Health and Medical Research Institute (SAHMRI) in Adelaide. [ + ]
